76359549 - GIGANUCLEASE

Information

• Trademark
• 76359549

• Source

• Serial Number

  76359549

• Registration Number

  2988451

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 16, 2002
  23 years ago

• Registration Date

  August 30, 2005
  20 years ago

• Transaction Date

  October 30, 2012
  13 years ago

• Status Date

  September 21, 2012
  13 years ago

• Published for Opposition Date

  June 07, 2005
  20 years ago

• Location Date

  August 30, 2005
  20 years ago

• Status Code

  710

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  LEVINE, HOWARD B

• Attorney Docket Number

  02-116T

  Attorney Name

  Barry L. Kelmachter

  Law Office Assigned Location Code

  M60

• Owners

  • Cellectis S.A.

Case File Statements

• GS0011: Chemicals, biochemical, biotechnological and bacteriological products namely, polypeptides for in vivo and invitro genetic engineering, natural and engineered meganuclease and endonuclease, nucleic acid vectors encoding the natural or engineered meganuclease or endonuclease or nucleic acid vectors comprising their recognition and cleavage site; ready to use genomic recombination system comprised primarily of reagents for scientific use; cells engineered by meganuclease recombination systems for scientific research use and therapeutic use, chemical agents, biochemical, biotechnologic and bacteriological products for use in scientific research laboratories and control laboratories namely cells, reagents, and culture media; diagnostic reagents for scientific use; proteins for use in scientific research; biotechnological preparations used as molecular scissors in scientific research
• GS0051: Pharmaceutical, veterinary, and health care products, namely polypeptides for in vivo and in vitro genetic engineering for use in the treatment of cystic fibrosis, Duchesne muscular dystrophy, and Alpha 1 antitrypsin disease; natural and engineered meganucleases and endonucleases, nucleic acid vectors encoding the natural or engineered meganuclease or endonuclease or nucleic acid vectors comprising their recognition and cleavage site, all for use in the treatment of sickle cell anemia, X-SciD, and Rs-SciD; ready to use genomic recombination system comprised primarily of meganuclease recombination system for use in the treatment of muscular dystrophy; cells engineered by meganuclease recombination system for use in the treatment of genetic and viral disease, microorganism cultures and bacteriological preparations for use in the treatment of genetic and viral disease; chemotherapeutic preparations for use in the treatment of cancer; diagnostic preparations for clinical medical use
• GS0421: Scientific and industrial research; research for others in genetic, medical, pharmaceutical, and veterinary fields; research for others in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis services, research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques, research and development of new molecules intended for industry, scientific laboratory services; conducting scientific research studies relating to engineering, natural, and engineered meganuclease and endonuclease, and meganuclease recombination systems; licensing of patents and of intellectual property; computer programming for others; and development for others of software programs and multimedia products

Case File Event Statements

• 9/21/2012 - 13 years ago

  30 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 8/30/2005 - 20 years ago

  29 - EXPARTE APPEAL TERMINATED Type: EXPT

• 8/30/2005 - 20 years ago

  28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/7/2005 - 20 years ago

  27 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/18/2005 - 20 years ago

  26 - NOTICE OF PUBLICATION Type: NPUB

• 2/18/2005 - 20 years ago

  25 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 2/15/2005 - 20 years ago

  24 - ASSIGNED TO LIE Type: ALIE

• 1/31/2005 - 20 years ago

  23 - ASSIGNED TO LIE Type: ALIE

• 1/26/2005 - 20 years ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/13/2004 - 21 years ago

  21 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT

• 7/28/2004 - 21 years ago

  20 - PAPER RECEIVED Type: MAIL

• 8/10/2004 - 21 years ago

  19 - PAPER RECEIVED Type: MAIL

• 8/10/2004 - 21 years ago

  18 - EX PARTE APPEAL-INSTITUTED Type: EXPI

• 8/4/2004 - 21 years ago

  17 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF

• 1/26/2004 - 21 years ago

  16 - FINAL REFUSAL MAILED Type: CNFR

• 10/24/2003 - 22 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/20/2003 - 21 years ago

  14 - CASE FILE IN TICRS Type: CFIT

• 10/24/2003 - 22 years ago

  13 - PAPER RECEIVED Type: MAIL

• 7/23/2003 - 22 years ago

  12 - LETTER OF SUSPENSION MAILED Type: CNSL

• 4/7/2003 - 22 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/7/2003 - 22 years ago

  10 - PAPER RECEIVED Type: MAIL

• 3/14/2003 - 22 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/14/2003 - 22 years ago

  8 - PAPER RECEIVED Type: MAIL

• 3/7/2003 - 22 years ago

  7 - LETTER OF SUSPENSION MAILED Type: CNSL

• 12/11/2002 - 22 years ago

  6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/11/2002 - 22 years ago

  5 - PAPER RECEIVED Type: MAIL

• 3/26/2002 - 23 years ago

  4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/19/2002 - 23 years ago

  3 - NON-FINAL ACTION MAILED Type: CNRT

• 3/26/2002 - 23 years ago

  2 - PAPER RECEIVED Type: MAIL

• 4/3/2002 - 23 years ago

  1 - ASSIGNED TO EXAMINER Type: DOCK